Data as of Jul 09
| +0.06 / +0.40%|
The 1 analysts offering 12-month price forecasts for Redhill Biopharma Ltd have a median target of 24.00, with a high estimate of 24.00 and a low estimate of 24.00. The median estimate represents a +60.86% increase from the last price of 14.92.
The current consensus among 1 polled investment analysts is to Buy stock in Redhill Biopharma Ltd. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.